Search
Feed aggregator
Sands Capital Launches $555M Life Sciences Fund Focusing on Private Companies
Sands Capital Launches $555M Life Sciences Fund Focusing on Private Companies 5/15/2024
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters 5/15/2024
FDA Delays Review by Three Months for Ascendis’ Hypoparathyroidism Therapy
FDA Delays Review by Three Months for Ascendis’ Hypoparathyroidism Therapy 5/15/2024
The Many Ways Biopharma Can Use Artificial Intelligence, Including Generative AI
The Many Ways Biopharma Can Use Artificial Intelligence, Including Generative AI 5/15/2024
Bayer Layoffs, a Big Alzheimer’s Deal, and ASGCT Wrap
Bayer Layoffs, a Big Alzheimer’s Deal, and ASGCT Wrap 5/15/2024
Bayer Cuts 1,500 Jobs and Lowers 2024 Earnings Guidance as Q1 Sales Dip
Bayer Cuts 1,500 Jobs and Lowers 2024 Earnings Guidance as Q1 Sales Dip 5/14/2024
Novo Nordisk’s Wegovy Sustains Weight Loss for Four Years in Two Studies
Novo Nordisk’s Wegovy Sustains Weight Loss for Four Years in Two Studies 5/14/2024
Cytokinetics’ Phase III Data Sets Up Cardiomyopathy Challenge to BMS
Cytokinetics’ Phase III Data Sets Up Cardiomyopathy Challenge to BMS 5/14/2024
AbbVie, Gilgamesh Sign Potential $2B Deal to Develop Next-Gen Psychedelics for Psychiatric Disorders
AbbVie, Gilgamesh Sign Potential $2B Deal to Develop Next-Gen Psychedelics for Psychiatric Disorders 5/14/2024
Sanofi, Pfizer, AstraZeneca Pledge Nearly $2.16B in Total Investments in France
Sanofi, Pfizer, AstraZeneca Pledge Nearly $2.16B in Total Investments in France 5/13/2024
Merck Ends Phase III Anti-TIGIT, Keytruda Skin Cancer Study with High Dropouts
Merck Ends Phase III Anti-TIGIT, Keytruda Skin Cancer Study with High Dropouts 5/13/2024
Takeda Inks Potential $2.2B Deal for AC Immune’s Alzheimer’s Immunotherapy
Takeda Inks Potential $2.2B Deal for AC Immune’s Alzheimer’s Immunotherapy 5/13/2024
BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs
BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs 5/13/2024
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy? 5/13/2024
Opinion: Travere’s Filspari Could Lead IgA Nephropathy Market
Opinion: Travere’s Filspari Could Lead IgA Nephropathy Market 5/13/2024
FDA Action Alert: Dynavax, Ascendis and BMS
FDA Action Alert: Dynavax, Ascendis and BMS 5/13/2024
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study
Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study 5/13/2024
Cut or Keep Running? How Companies Respond to Failed Confirmatory Trials
Cut or Keep Running? How Companies Respond to Failed Confirmatory Trials 5/13/2024
Lilly’s Tirzepatide Shows Positive Phase II NASH Data, Tees Up Potential Expa...
Lilly’s Tirzepatide Shows Positive Phase II NASH Data, Tees Up Potential Expa... 6/5/2024
FDA Adcomm Votes Against Lykos’ MDMA-Assisted PTSD Therapy
FDA Adcomm Votes Against Lykos’ MDMA-Assisted PTSD Therapy 6/5/2024
World Pharma News
- Up to one-third of antibody drugs are nonspecific
- More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050
- How the immune system fails as cancer arises
- Laughter may be as effective as drops for dry eyes
- Pfizer highlights diverse oncology oortfolio and combination approaches at ESMO 2024